Evaluation of EFficacy and SaFEty of Leukotac (Inolimomab) in Pediatric Patients With SR-aGvHD
NCT04289103
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
65
Enrollment
INDUSTRY
Sponsor class
Conditions
Steroid Refractory GVHD
Interventions
BIOLOGICAL:
Inolimomab (Leukotac)
Sponsor
ElsaLys Biotech